Oaktree Acquisition Corp. III Life Sciences OACC

OACCW extends merger deadline

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Extension to November 25, 2026
  2. Potential for up to 7 months extension
  3. Meeting on October 16, 2026
  4. Redemption price of $10.75 per share

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Get an email when Oaktree Acquisition Corp. III Life Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 6770 and related industry codes: the same peer list as the financial tables.